Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review

Sara Pietracupa1, Antonio Martin-Bastida2, Paola Piccini2

  • 1IRCSS Neuromed, Pozzilli, Italy. sara.pietracupa@uniroma1.it.

Insights

Brain iron accumulation is common in Parkinson's disease (PD). This review summarizes research on brain iron deposition in PD, exploring its role in neurodegeneration and assessment via magnetic resonance imaging (MRI).

Area of Science:

  • Neuroscience
  • Radiology
  • Neurology

Background:

  • Iron deposition in the brain increases with age and is implicated in neurodegenerative diseases like Parkinson's disease (PD).
  • The precise role of iron overload in dopaminergic neuronal death in PD remains unclear.
  • Accurate assessment of brain iron content is crucial for understanding PD progression.

Purpose of the Study:

  • To review and summarize current data on brain iron deposition in Parkinson's disease.
  • To discuss the potential link between iron overload and neurodegeneration in PD.
  • To highlight the utility of MRI techniques in assessing brain iron.

Main Methods:

  • Review of existing literature on brain iron in PD.
  • Discussion of magnetic resonance imaging (MRI) techniques for iron detection.
  • Focus on T2*-weighted gradient-echo (GRE) and susceptibility-weighted imaging (SWI) sequences.

Main Results:

  • Brain iron accumulation is a recognized feature in PD.
  • MRI, particularly T2*-GRE and SWI, are valuable tools for visualizing iron in basal ganglia.
  • Further research is needed to establish causality between iron overload and neuronal death in PD.

Conclusions:

  • Brain iron deposition is a significant factor in Parkinson's disease.
  • Advanced MRI techniques offer promising methods for evaluating brain iron.
  • Understanding iron's role is key to unraveling PD pathogenesis.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
10.0K